Document Detail


Emerging Biomarkers in Heart Failure.
MedLine Citation:
PMID:  22086968     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Until recently, biomarker testing in heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patients suspected to suffer from this condition. This approach to the use of biomarker testing contrasts with other cardiovascular diagnoses such as acute myocardial infarction, for which biomarkers are integral to disease process definition, risk stratification, and in some cases treatment decision making. CONTENT: In this review we consider various perspectives on the evaluation of biomarkers in HF. In addition, we examine recent advances in the understanding of established biomarkers in HF (such as the natriuretic peptides), the elucidation of novel biomarkers potentially useful for the evaluation and management of patients with HF, and the growing understanding of important and relevant comorbidities in HF. We also review candidate biomarkers from a number of classes: (a) myocyte stretch, (b) myocyte necrosis, (c) systemic inflammation, (d) oxidative stress, (e) extracellular matrix turnover, (f) neurohormones, and (g) biomarkers of extracardiac processes, such as renal function. SUMMARY: Novel applications of established biomarkers of HF as well as elucidation and validation of emerging assays for HF syndromes have collectively led to a growing interest in the more widespread use of such testing in patients affected by the diagnosis.
Authors:
Roland R J van Kimmenade; James L Januzzi
Related Documents :
21835758 - Diagnostic and prognostic value of doppler echocardiographic coronary flow reserve in t...
21411338 - Ischemic stroke of the pyramidal decussation causing quadriplegia and anarthria.
21216378 - Cardiac tamponade secondary to fulminant myocarditis - a case of custodial death.
21914028 - Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation.
12797618 - The stress-strain behavior of coronary stent struts is size dependent.
10562478 - New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasoun...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-15
Journal Detail:
Title:  Clinical chemistry     Volume:  -     ISSN:  1530-8561     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Stud...
Next Document:  Use of Natriuretic Peptides to Guide and Monitor Heart Failure Therapy.